Biblio
Correction: The YAP1 Signaling Inhibitors, Verteporfin and CA3, Suppress the Mesothelioma Cancer Stem Cell Phenotype. Mol Cancer Res. 2023;21(9):991.
. . Structure-activity relationships of N-terminal variants of peptidomimetic tissue transglutaminase inhibitors. Eur J Med Chem. 2022;232:114172.
. .
.
Transglutaminase is a tumor cell and cancer stem cell survival factor. Mol Carcinog. 2015.
. TRANSGLUTAMINASE IS REQUIRED FOR EPIDERMAL SQUAMOUS CELL CARCINOMA STEM CELL SURVIVAL. Mol Cancer Res. 2015.
. Suppressing AP1 Factor Signaling in Suprabasal Epidermis Produces A Keratoderma Phenotype. J Invest Dermatol. 2014.
.